Page last updated: 2024-08-25

8-(4-tolylsulfonylamino)quinoline and Disease Exacerbation

8-(4-tolylsulfonylamino)quinoline has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, JY; Hong, S; Jung, Y; Kim, JH; Kweon, DH; Lee, J; Park, KW; Yang, WS; Yi, YS; Yoo, DS1

Other Studies

1 other study(ies) available for 8-(4-tolylsulfonylamino)quinoline and Disease Exacerbation

ArticleYear
8-(Tosylamino)quinoline inhibits tumour progression through targeting phosphoinositide-3-kinase/Akt pathway.
    Die Pharmazie, 2013, Volume: 68, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chorioallantoic Membrane; Disease Progression; Humans; Immunoprecipitation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasm Invasiveness; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Quinolines; Tosyl Compounds; Wound Healing

2013